For the more than 23 million people living with diabetes, blood glucose level testing is critical to maintaining a healthy lifestyle. Singer/songwriter Nick Jonas has type 1 diabetes and personally checks his blood glucose levels up to 12 times a day with the CONTOUR USB® meter. He is working with Bayer Diabetes Care to remind people with diabetes to learn about the importance of blood glucose testing and what has an impact on blood sugar levels, including certain foods, types of exercise, emotions and stress levels. Testing frequently, in accordance with a doctor’s guidance, helps a person with diabetes make important choices throughout the day to stay within a target blood glucose range.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/bayer/47240/
OneTouch®, a leading brand of blood glucose monitoring systems for people with diabetes, has introduced Life First™, a new North American campaign featuring music legend B.B. King and Crystal Bowersox, one of music’s most talented new artists. The ads debut on national and regional television today and will be followed by online and print ads over the next several months. The introduction of the campaign is particularly timely, since March 22 marks National Diabetes Alert Day in the U.S.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/onetouch/48943/
New research debuted at the American Diabetes Association’s 72nd Annual Scientific Session suggests eating raisins three times a day may significantly lower postprandial (post-meal) glucose levels when compared to common alternative snacks of equal caloric value. The study was conducted at the Louisville Metabolic and Atherosclerosis Center (L-MARC) by lead researcher, Harold Bays, MD, medical director and president of L-MARC.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56845-california-raisin-marketing-board-raisins-reduce-post-meal-blood-sugar
As part of their ongoing partnership to help Americans improve their health and curb the onset of chronic diseases like diabetes, CVS/pharmacy and the 50 Million Pound Challenge announced today the availability of the 32-page 50 Million Pound Challenge Guide in all CVS/pharmacy retail locations.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/cvs/43523/
Two Merck research scientists, Nancy A. Thornberry and Ann E. Weber, Ph.D., will receive the Discoverers Award, the highest honor from the Pharmaceutical Research and Manufacturers of America (PhRMA), during a ceremony tonight at the Liberty Science Center in Jersey City, N.J.
They will be recognized for their leadership in the discovery of JANUVIA®, a once-daily pill that helps patients with type 2 diabetes control glucose in conjunction with diet and exercise. Though women have been part of teams honored with the Discoverers Award in the past, this is the first time in the award’s 24-year history that women alone have won.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/phrma/49723/
Beginning in mid-March, the AARP/Walgreens Wellness Tour will once again travel the country, embarking on a ten-month tour to provide an expected $14 million worth of free health tests. The national mobile tour will conduct free health-testing events in communities throughout the United States and Puerto Rico. The free tests—which include total cholesterol levels, blood pressure, bone density, glucose levels, waist circumference and body mass index—are valued at $100 per person and may help provide adults with a critical foundation for early disease detection and prevention.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/walgreens/48029/
Diabetes experts met and determined that some self-monitoring blood glucose (SMBG) systems, despite meeting accuracy standards at the time of U.S. Food and Drug Administration (FDA) clearance, fail to consistently meet accuracy standards once on the market, potentially putting patient health at risk. In a public meeting convened by the Diabetes Technology Society on May 21, 2013, in Arlington, Virginia, leading academic clinicians, clinical chemists, medical device experts, patient advocates and FDA representatives reviewed a growing body of peer-reviewed research demonstrating that the performance of some blood glucose monitors on the market may not be meeting accuracy standards.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/61870-diabetes-technology-society-inaccurate-blood-glucose-monitors-risky
Today, WebMD Health Corp. (NASDAQ: WBMD) launched WebMD Healthy Target, an integrated health improvement program that uses biometric device data from activity trackers, wireless scales and glucose meters to deliver tailored, physician-reviewed, contextually relevant content and motivational tips to individuals looking to develop sustainable health-conscious habits. WebMD Healthy Target will provide valuable assistance to individuals looking to manage chronic conditions like Type 2 diabetes and obesity, as well as to a broader audience interested in achieving their fitness goals or more generally living a healthier lifestyle.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/70402510-webmd-launches-health-improvement-program-for-iphone/
Today, WebMD Health Corp. (NASDAQ: WBMD) announced new features and functionality for its Healthy Target behavior change program that connects seamlessly with Apple’s HealthKit and provides users with powerful new ways to capture, visualize and understand health information from a broad range of biometric devices.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/70402511-web-md-updates-healthy-target-behavior-change-program-apple-healthkit/
ACCU-CHEK Aviva Expert offers people with diabetes a new and easy way to simplify complex calculations to deliver precise insulin dosing advice.
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the ACCU-CHEK® Aviva Expert system, the first and only blood glucose meter system with a built-in insulin calculator to be approved by the U.S. Food and Drug Administration (FDA), is now available by prescription. The device represents a significant advancement in blood glucose meter technology for people with diabetes who take multiple daily insulin injections. The meter’s integrated bolus calculator provides easy-to-use and reliable dose recommendations based on automated calculations, eliminating the need for manual dosing calculations and estimations.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7322751-roche-accu-chek-aviva-expert-blood-glucose-meter-now-available/
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and the American Diabetes Association today issued a new challenge to the millions of Americans affected by type 2 diabetes as part of the program America’s Diabetes Challenge: Get to Your Goals. In 2015, award-winning artist Tim McGraw, celebrated actress S. Epatha Merkerson and chef Leticia Moreinos Schwartz each shared their personal connection to type 2 diabetes. This year, they’re calling on people to share their stories.
Living with diabetes isn’t easy, and that’s why America’s Diabetes Challenge encourages people with type 2 diabetes to work with their doctor to set and reach their A1C goal. The program will aim to identify the most common challenges patients submit and will offer tips to help address them. The program is also designed to help people learn if they’re at risk of low blood glucose, known as hypoglycemia, and how to help reduce that risk.
To view the multimedia release go to:
http://www.multivu.com/players/English/7785551-merck-americas-diabetes-challenge/
